Edinburgh Research Explorer

Prof John Smyth

(Former employee or visitor)

  1. 2002
  2. Neuregulin expression, function, and signaling in human ovarian cancer cells

    Gilmour, L. M. R., Macleod, K. G., McCaig, A., Sewell, J. M., Gullick, W. J., Smyth, J. F. & Langdon, S. P., Dec 2002, In : Clinical Cancer Research. 8, 12, p. 3933-42 10 p.

    Research output: Contribution to journalArticle

  3. CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine-sensitive subgroup

    Bowman, A., Gabra, H., Langdon, S. P., Lessells, A., Stewart, M., Young, A. & Smyth, J. F., Jul 2002, In : Clinical Cancer Research. 8, 7, p. 2233-9 7 p.

    Research output: Contribution to journalArticle

  4. Malignant mixed mesodermal tumours: biology and clinical aspects

    Gourley, C., Al-Nafussi, A., Abdulkader, M., Smyth, J. F. & Gabra, H., Jul 2002, In : European journal of cancer (Oxford, England : 1990). 38, 11, p. 1437-46 10 p.

    Research output: Contribution to journalArticle

  5. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters

    Oberst, M. D., Johnson, M. D., Dickson, R. B., Lin, C-Y., Singh, B., Stewart, M., Williams, A., al-Nafussi, A., Smyth, J. F., Gabra, H. & Sellar, G. C., Apr 2002, In : Clinical Cancer Research. 8, 4, p. 1101-7 7 p.

    Research output: Contribution to journalArticle

  6. Identification of differentially expressed mRNAS associated with chromosome 11 transfer into the ovarian cancer cell line OVCAR3

    Blenkiron, C., Stronach, E. A., Sellar, G. C., Rabiasz, G. J., Miller, E. P., Porteous, D. J., Smyth, J. F. & Gabra, H., 2002, In : British Journal of Cancer. 86, p. S90-S90

    Research output: Contribution to journalArticle

  7. OBCAM, an IgLON cell adhesion molecule from 11q25, is frequently inactivated in sporadic epithelial ovarian cancer

    Sellar, G. C., Watt, K. P., Stronach, E. A., Rabiasz, G. J., Miller, E. P., Massie, C., Scott, D., Porteous, D. J., Smyth, J. F. & Gabra, H., 2002, In : Proceedings of the American Association for Cancer Research Annual Meeting. 43, p. 146 1 p.

    Research output: Contribution to journalArticle

  8. The homeobox gene BARX2 can modulate cisplatin sensitivity in human epithelial ovarian cancer

    Sellar, G. C., Watt, K. P., Li, L., Nelkin, B. D., Rabiasz, G. J., Porteous, D. J., Smyth, J. F. & Gabra, H., 2002, In : International journal of oncology. 21, 5, p. 929-33 5 p.

    Research output: Contribution to journalArticle

  9. 2001
  10. Adjuvant interferon alpha 2b in high risk melanoma - the Scottish study

    Cameron, D. A., Cornbleet, M. C., Mackie, R. M., Hunter, J. A., Gore, M., Hancock, B., Smyth, J. F. & Scottish Melanoma Group, 4 May 2001, In : British Journal of Cancer. 84, 9, p. 1146-9 4 p.

    Research output: Contribution to journalArticle

  11. Functional identification of RALDH2 dysregulation by cDNA representational difference analysis in chromosome 11 mediated growth suppression of ovarian cancer

    Blenkiron, C., Sellar, G. C., Stronach, E., Rabiasz, G. J., Miller, E. P., Porteous, D. J., Smyth, J. F. & Gabra, H., 2001, In : British Journal of Cancer. 85, p. 73javascript:void(0); 1 p.

    Research output: Contribution to journalArticle

  12. 1996
  13. A statistical analysis of chromosome 11 and 17 loss of heterozygosity in epithelial ovarian cancer

    Gabra, H., Watson, J., Eccles, D., Taylor, L., Taylor, K., Cohen, B., Leonard, R., Porteous, D., Smyth, J. & Steel, C., 1996, In : International journal of oncology. 8, 3, p. 625-31 7 p.

    Research output: Contribution to journalArticle